John MS - Tango Therapeutics Vice Resources
| TNGX Stock | USD 7.59 0.31 4.26% |
Executive
John MS is Vice Resources of Tango Therapeutics
| Address | 201 Brookline Avenue, Boston, MA, United States, 02215 |
| Phone | 857 320 4900 |
| Web | https://www.tangotx.com |
Tango Therapeutics Management Efficiency
The company has return on total asset (ROA) of (0.1701) % which means that it has lost $0.1701 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4049) %, meaning that it created substantial loss on money invested by shareholders. Tango Therapeutics' management efficiency ratios could be used to measure how well Tango Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.25 in 2024. Return On Capital Employed is likely to drop to -0.34 in 2024. At this time, Tango Therapeutics' Net Tangible Assets are fairly stable compared to the past year. Asset Turnover is likely to rise to 0.15 in 2024, whereas Total Assets are likely to drop slightly above 352.5 M in 2024.Similar Executives
| Found 13 records | EXECUTIVE Age | ||
| Karen Brunke | Jaguar Animal Health | 71 | |
| David Hava | Pulmatrix | 40 | |
| Robert CPA | Acasti Pharma | 52 | |
| Carol MBA | Jaguar Animal Health | 60 | |
| Brian Groch | Acasti Pharma | N/A | |
| Philippe Brianceau | Jaguar Animal Health | N/A | |
| David JD | Pulmatrix | 66 | |
| Serge Martinod | Jaguar Animal Health | 57 | |
| John JD | Adial Pharmaceuticals | N/A | |
| Peter Hodge | Jaguar Animal Health | N/A | |
| James Roach | Pulmatrix | N/A | |
| Bankole Johnson | Adial Pharmaceuticals | 58 | |
| Roger Waltzman | Jaguar Animal Health | N/A | |
Management Performance
| Return On Equity | -0.4 | ||||
| Return On Asset | -0.17 |
Tango Therapeutics Leadership Team
Elected by the shareholders, the Tango Therapeutics' board of directors comprises two types of representatives: Tango Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Tango. The board's role is to monitor Tango Therapeutics' management team and ensure that shareholders' interests are well served. Tango Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Tango Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| MD Kaelin, Founder Board | ||
| Michael Palmieri, Manufacturing, Chemistry | ||
| Jannik Andersen, Chief Officer | ||
| Antoni MD, Founder Board | ||
| John MS, Vice Resources | ||
| Barbara MD, CEO President | ||
| Daniella CPA, Chief Officer | ||
| Alan Huang, Chief Officer | ||
| Levi MD, Founder | ||
| JD Esq, Chief Counsel | ||
| Alan FRS, Founder Board |
Tango Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Tango Therapeutics a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.4 | ||||
| Return On Asset | -0.17 | ||||
| Profit Margin | (2.79) % | ||||
| Operating Margin | (6.45) % | ||||
| Current Valuation | 478.94 M | ||||
| Shares Outstanding | 106.73 M | ||||
| Shares Owned By Insiders | 13.50 % | ||||
| Shares Owned By Institutions | 88.53 % | ||||
| Number Of Shares Shorted | 10.63 M | ||||
| Price To Book | 3.10 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Tango Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Tango Therapeutics' short interest history, or implied volatility extrapolated from Tango Therapeutics options trading.
Currently Active Assets on Macroaxis
When determining whether Tango Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Tango Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Tango Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Tango Therapeutics Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tango Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. For more information on how to buy Tango Stock please use our How to Invest in Tango Therapeutics guide.Note that the Tango Therapeutics information on this page should be used as a complementary analysis to other Tango Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Complementary Tools for Tango Stock analysis
When running Tango Therapeutics' price analysis, check to measure Tango Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tango Therapeutics is operating at the current time. Most of Tango Therapeutics' value examination focuses on studying past and present price action to predict the probability of Tango Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tango Therapeutics' price. Additionally, you may evaluate how the addition of Tango Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |
Is Tango Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tango Therapeutics. If investors know Tango will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tango Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.08) | Revenue Per Share 0.386 | Quarterly Revenue Growth (0.15) | Return On Assets (0.17) | Return On Equity (0.40) |
The market value of Tango Therapeutics is measured differently than its book value, which is the value of Tango that is recorded on the company's balance sheet. Investors also form their own opinion of Tango Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Tango Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tango Therapeutics' market value can be influenced by many factors that don't directly affect Tango Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tango Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Tango Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tango Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.